ature-based therapy for Metabolic Syndrome - Salzburg

Paracelsus Medical University0 个研究点目标入组 140 人开始时间: 2024年6月10日最近更新: 2024年6月24日

适应症

试验速览

暂无简介。

•1. Individuals aged between 40 and 65 of any gender
•2. Individuals diagnosed with metabolic syndrome according to the NCEP ATP III criteria (NCEP, 2001)
•3. Sedentary lifestyle: Category 1 (low physical activity) of the International Physical Activity Questionnaire – Short Form (IPAQ-SF))
•4. Low nature users: Category 1, 2 und 3 of the Monitor of Engagement with the Natural Environment Survey (MENE) – question nature use” (Natural England, 2020)
•5. Smartphone users

•1.Acute contraindications:
•1.1.Malignant hypertension
•2.Contraindications or differential diagnosis
•2.1.Severe respiratory or lung disease (COPD according to GOLD Standard 3 and 4, severe asthma, emphysema)
•2.2.Arteriosclerotic event (e.g. myocardial infarction) < 6 months ago
•2.3.Uncontrolled metabolic diseases (e.g. uncontrolled diabetes mellitus)
•2.4.insulin-dependent diabetes mellitus
•2.5.Diagnosis or treatment of a malignant tumors < 3 years in the past
•2.6.Orthopedic illnesses that do not allow participation in hikes
•3.Factors that prevent or hinder participation in the intervention program
•3.1.Alcohol abuse
•3.2.Pregnancy
•3.3.insufficient knowledge of German language (written and spoken)
•4.Factors that prevent self-management:
•4.1.Presence or indication of clinical depression (< 13 points WHO-5)
•4.2.Serious other untreated psychiatric illnesses (e.g. schizophrenia)
•5.Certain medication intake:
•5.1.Taking preparations for weight reduction
•6.Participation in another interventional study within the period of the clinical trial (t1-t4) and less than 4 weeks before the start of the trial (t1)
•7.Participation in therapeutic weight loss programs within the period of the clinical study (t1-t4) and less than 8 weeks before the start of the study (t1)

发起方

Paracelsus Medical University